A patient’s blood type plays a role in the likelihood of developing COVID-19, data from two genetic studies show.
An infectious disease expert unaffiliated with the studies told Healio Primary Care that the results are possible, but with some important caveats.
In the first study, which appeared in The New England Journal of Medicine, David Ellinghaus, a scientist at the Institute of Clinical Molecular Biology in Germany, and colleagues analyzed nearly 8.6 million single nucleotide polymorphisms from 1,610 Spanish and Italian patients with COVID-19 and respiratory failure. Another 2,205
Uncategorized